University of Kansas Medical Center (Site 1020) — Kansas City, Missouri

University of Kansas Medical Center (Site 1020) is a clinical research site located in Kansas City, Missouri, United States 66160-7232.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Kansas Medical Center (Site 1020) has participated in 1 clinical trials.

Therapeutic areas: Pulmonary Arterial Hypertension.

Sponsors: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Kansas Medical Center (Site 1020)?

University of Kansas Medical Center (Site 1020) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Kansas Medical Center (Site 1020) conducted?

University of Kansas Medical Center (Site 1020) has 1 clinical trials on record. Their work covers Pulmonary Arterial Hypertension.

Is University of Kansas Medical Center (Site 1020) accredited by Crixeo Health?

University of Kansas Medical Center (Site 1020) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Kansas Medical Center (Site 1020)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.